Literature DB >> 3919113

Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.

G B Pier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919113     DOI: 10.1093/infdis/151.4.575

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  81 in total

1.  Abnormal fucosylation of-ileal mucus in cystic fibrosis: II. A histochemical study using monoclonal antibodies to fucosyl oligosaccharides.

Authors:  A King; M McLeish; S Thiru
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Abnormal fucosylation of ileal mucus in cystic fibrosis: I. A histochemical study using peroxidase labelled lectins.

Authors:  S Thiru; G Devereux; A King
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

Review 3.  Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy.

Authors:  H Anwar; J L Strap; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 4.  Cystic fibrosis, pathophysiological and clinical aspects.

Authors:  H J Neijens; M Sinaasappel; R de Groot; J C de Jongste; S E Overbeek
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

5.  AlgX is a periplasmic protein required for alginate biosynthesis in Pseudomonas aeruginosa.

Authors:  Antonette Robles-Price; Thiang Yian Wong; Håvard Sletta; Svein Valla; Neal L Schiller
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

6.  Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis.

Authors:  G Steinkamp; B Tümmler; R Malottke; H von der Hardt
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

7.  Pseudomonas aeruginosa antibodies in blood spots from patients with cystic fibrosis.

Authors:  V Thanasekaraan; M S Wiseman; R J Rayner; E J Hiller; D J Shale
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

8.  A major Pseudomonas aeruginosa clone common to patients and aquatic habitats.

Authors:  U Römling; J Wingender; H Müller; B Tümmler
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

9.  Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.

Authors:  J L Gaillard; P Cahen; C Delacourt; C Silly; M Le Bourgeois; C Coustère; J de Blic; G Lenoir; P Scheinmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

10.  Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa.

Authors:  H Grundmann; C Schneider; D Hartung; F D Daschner; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.